“Antiproliferative activity of the bioactive compound from Silybum marianum in a human melanoma cell line with BRAF mutation: potential for therapeutic repurposing” (2025) Revista Fitos, 19, p. e1812. doi:10.32712/2446-4775.2025.1812.